1[1]He X,Semenov M,Tamai K.et al.LDL receptor-related protein 5 and 6 in Wnt/beta-catenia signaling arrows point the way[J].Development,2004,131:1663-1677.
2[2]Toomes C,Bottomley HB,Richard M,et al.Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q[J].Cell,2001,107:513-523.
3[3]Westendorf JJ,Kahler RA,Schroeder TM,et al.Wnt signaling in osteoblasts and bone diseases[J].Gene,2004,341:19-39.
4[4]Hey PJ,Twells RC,Phillips MS,et al.Cloning of a novel member of the low-density lipoprotein receptor family[J].Gene,1998,216:103-111.
5[5]Dong Y,Lathrop W,Weaver D,et al.Moleular clo ning and characterization of LR3,a novel LDL receptor family protein with mitogenic activity[J].Biochem Biophys Res Commun,1998,251:784-790.
6[6]Koh JM,Jung MH,Hong JS,et al.Association between Bone Mineral Density and LDL Receptor-Related Protein 5 Gene Polymorphisms in Young Korean Men[J].J Korean Med Sci,2004,19:407-412.
7[7]Van Hul E,Gram J,Bollerslev J,et al.Location of the gene causing autosomal dominant osteoporosis type Ⅰ to chromosome[J].JBMR,2002,17:1111-1113.
8[8]Gong YQ,Roger B,Fukai SN,et al.LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development[J].Cell,2001,107..513-523.
9[9]Little RD,Carulli JP,Mastro DRG,et al.A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high bone-mass trait[J].Am J Hum Genet,2002,70:11-19.
10[10]Boyden LM,MAO J,BELSKY J,et al.High bone density due to a mutation in LDL-receptor-related protein 5[J].N Engl J Med,2002,346:1513-1521.
6Yamaguchi, Sugimoto T. Calcium homeostasis and osteroprosis in diabetes mellitus and the metabolic syndrome [ J ]. Clin Calcium,2008,18 (7) :904-911.
7Popov AA, Izmozherova NV, Tagil' tseva NV, et al. Meta-bolic syndrome and decreased bone mineral density in climacteric women [J]. Klin Med (Mosk) , 2008,86 (9) : 51- 53.
8Yamaguchi T. Osteoporosis associated with the metaolic syndrome [ J ]. Clin Calcium,2008,18 ( 5 ) :606-611.
